Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
167.4 USD | -0.22% | +1.49% | +7.84% |
05:07pm | AbbVie Says Rinvoq Shows Superiority Versus Dupixent in Atopic Dermatitis Trial Primary Endpoint | MT |
12:11pm | Scholz promises support for pharma sector in Germany as Merck invests | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.84% | 297B | |
+24.17% | 562B | |
-6.45% | 358B | |
+19.93% | 322B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-11.98% | 149B | |
-6.71% | 146B | |
+2.07% | 117B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie Said to Push Two New Immune Medicines, Lift $2 Billion Cap on Dealmaking